AVX Pharma
Developing novel drugs addressing major ophthalmic unmet medical needs, with especial focus on ocular surface diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$11—17m (Dealroom.co estimates Oct 2014.)
Barcelona Catalonia (HQ & founding location)
Authorizing premium user...